IDEAS home Printed from https://ideas.repec.org/a/spr/pharme/v38y2020i7d10.1007_s40273-020-00903-9.html
   My bibliography  Save this article

R and Shiny for Cost-Effectiveness Analyses: Why and When? A Hypothetical Case Study

Author

Listed:
  • Rose Hart

    () (BresMed Health Solutions)

  • Darren Burns

    (BresMed Health Solutions)

  • Bram Ramaekers

    (Maastricht University Medical Center)

  • Shijie Ren

    (University of Sheffield)

  • Daniel Gladwell

    (BresMed Health Solutions)

  • Will Sullivan

    (BresMed Health Solutions)

  • Niall Davison

    (BresMed Health Solutions)

  • Owain Saunders

    (BresMed Health Solutions)

  • Indeg Sly

    (BresMed Health Solutions)

  • Theresa Cain

    (BresMed Health Solutions)

  • Dawn Lee

    (BresMed Health Solutions)

Abstract

Introduction Health economics models are typically built in Microsoft Excel® owing to its wide familiarity, accessibility and perceived transparency. However, given the increasingly rapid and analytically complex decision-making needs of both the pharmaceutical industry and the field of health economics and outcomes research (HEOR), the demands of cost-effectiveness analyses may be better met by the programming language R. Objective This case study provides an explicit comparison between Excel and R for contemporary cost-effectiveness analysis. Methods We constructed duplicate cost-effectiveness models using Excel and R (with a user interface built using the Shiny package) to address a hypothetical case study typical of contemporary health technology assessment. Results We compared R and Excel versions of the same model design to determine the advantages and limitations of the modelling platforms in terms of (i) analytical capability, (ii) data safety, (iii) building considerations, (iv) usability for technical and non-technical users and (v) model adaptability. Conclusions The findings of this explicit comparison are used to produce recommendations for when R might be more suitable than Excel in contemporary cost-effectiveness analyses. We conclude that selection of appropriate modelling software needs to consider case-by-case modelling requirements, particularly (i) intended audience, (ii) complexity of analysis, (iii) nature and frequency of updates and (iv) anticipated model run time.

Suggested Citation

  • Rose Hart & Darren Burns & Bram Ramaekers & Shijie Ren & Daniel Gladwell & Will Sullivan & Niall Davison & Owain Saunders & Indeg Sly & Theresa Cain & Dawn Lee, 2020. "R and Shiny for Cost-Effectiveness Analyses: Why and When? A Hypothetical Case Study," PharmacoEconomics, Springer, vol. 38(7), pages 765-776, July.
  • Handle: RePEc:spr:pharme:v:38:y:2020:i:7:d:10.1007_s40273-020-00903-9
    DOI: 10.1007/s40273-020-00903-9
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40273-020-00903-9
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Blog mentions

    As found by EconAcademics.org, the blog aggregator for Economics research:
    1. Chris Sampson’s journal round-up for 29th June 2020
      by Chris Sampson in The Academic Health Economists' Blog on 2020-06-29 11:00:06

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:pharme:v:38:y:2020:i:7:d:10.1007_s40273-020-00903-9. See general information about how to correct material in RePEc.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Sonal Shukla) or (Springer Nature Abstracting and Indexing). General contact details of provider: http://www.springer.com .

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service hosted by the Research Division of the Federal Reserve Bank of St. Louis . RePEc uses bibliographic data supplied by the respective publishers.